Global Chronic Spontaneous Urticaria Market Growth (Status and Outlook) 2025-2031--LP INFORMATION, INC.

Global Chronic Spontaneous Urticaria Market Growth (Status and Outlook) 2025-2031

Product Code: 1478429

Industry: Medical Care

Published: Apr 10,2025

Pages: 138

Delivery Time: 2-3 business days

Global Chronic Spontaneous Urticaria Market Growth (Status and Outlook) 2025-2031

Product Code: 1478429

Industry: Medical Care

Published: Apr 10,2025

Pages: 138

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Chronic Spontaneous Urticaria market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Chronic Spontaneous Urticaria Industry Forecast” looks at past sales and reviews total world Chronic Spontaneous Urticaria sales in 2024, providing a comprehensive analysis by region and market sector of projected Chronic Spontaneous Urticaria sales for 2025 through 2031. With Chronic Spontaneous Urticaria sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chronic Spontaneous Urticaria industry.

This Insight Report provides a comprehensive analysis of the global Chronic Spontaneous Urticaria landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Chronic Spontaneous Urticaria portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chronic Spontaneous Urticaria market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chronic Spontaneous Urticaria and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chronic Spontaneous Urticaria.

This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Spontaneous Urticaria market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Antihistamine

    Monoclonal Antibody

    Other

Segmentation by Application:

    Children

    Adult

This report also splits the market by region:

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Mylan N. V.

    Sanofi

    GlaxoSmithKline

    Bayer

    Merck

    Aurobindo Pharma

    Hikma Pharmaceuticals

    WOCKHARDT

    AbbVie, Inc.

    Cipla Inc.

    F. Hoffmann La Roche Ltd.

    Teva Pharmaceutical Industries, Ltd.

    Pfizer, Inc.

    Novartis AG

    Eli Lilly and Company

    Allergan

    Lupin

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Chronic Spontaneous Urticaria Market Size (2020-2031)
        2.1.2 Chronic Spontaneous Urticaria Market Size CAGR by Region (2020 VS 2024 VS 2031)
        2.1.3 World Current & Future Analysis for Chronic Spontaneous Urticaria by Country/Region (2020, 2024 & 2031)
    2.2 Chronic Spontaneous Urticaria Segment by Type
        2.2.1 Antihistamine
        2.2.2 Monoclonal Antibody
        2.2.3 Other
    2.3 Chronic Spontaneous Urticaria Market Size by Type
        2.3.1 Chronic Spontaneous Urticaria Market Size CAGR by Type (2020 VS 2024 VS 2031)
        2.3.2 Global Chronic Spontaneous Urticaria Market Size Market Share by Type (2020-2025)
    2.4 Chronic Spontaneous Urticaria Segment by Application
        2.4.1 Children
        2.4.2 Adult
    2.5 Chronic Spontaneous Urticaria Market Size by Application
        2.5.1 Chronic Spontaneous Urticaria Market Size CAGR by Application (2020 VS 2024 VS 2031)
        2.5.2 Global Chronic Spontaneous Urticaria Market Size Market Share by Application (2020-2025)

3 Chronic Spontaneous Urticaria Market Size by Player
    3.1 Chronic Spontaneous Urticaria Market Size Market Share by Player
        3.1.1 Global Chronic Spontaneous Urticaria Revenue by Player (2020-2025)
        3.1.2 Global Chronic Spontaneous Urticaria Revenue Market Share by Player (2020-2025)
    3.2 Global Chronic Spontaneous Urticaria Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Chronic Spontaneous Urticaria by Region
    4.1 Chronic Spontaneous Urticaria Market Size by Region (2020-2025)
    4.2 Global Chronic Spontaneous Urticaria Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Chronic Spontaneous Urticaria Market Size Growth (2020-2025)
    4.4 APAC Chronic Spontaneous Urticaria Market Size Growth (2020-2025)
    4.5 Europe Chronic Spontaneous Urticaria Market Size Growth (2020-2025)
    4.6 Middle East & Africa Chronic Spontaneous Urticaria Market Size Growth (2020-2025)

5 Americas
    5.1 Americas Chronic Spontaneous Urticaria Market Size by Country (2020-2025)
    5.2 Americas Chronic Spontaneous Urticaria Market Size by Type (2020-2025)
    5.3 Americas Chronic Spontaneous Urticaria Market Size by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Chronic Spontaneous Urticaria Market Size by Region (2020-2025)
    6.2 APAC Chronic Spontaneous Urticaria Market Size by Type (2020-2025)
    6.3 APAC Chronic Spontaneous Urticaria Market Size by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Chronic Spontaneous Urticaria Market Size by Country (2020-2025)
    7.2 Europe Chronic Spontaneous Urticaria Market Size by Type (2020-2025)
    7.3 Europe Chronic Spontaneous Urticaria Market Size by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Chronic Spontaneous Urticaria by Region (2020-2025)
    8.2 Middle East & Africa Chronic Spontaneous Urticaria Market Size by Type (2020-2025)
    8.3 Middle East & Africa Chronic Spontaneous Urticaria Market Size by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Global Chronic Spontaneous Urticaria Market Forecast
    10.1 Global Chronic Spontaneous Urticaria Forecast by Region (2026-2031)
        10.1.1 Global Chronic Spontaneous Urticaria Forecast by Region (2026-2031)
        10.1.2 Americas Chronic Spontaneous Urticaria Forecast
        10.1.3 APAC Chronic Spontaneous Urticaria Forecast
        10.1.4 Europe Chronic Spontaneous Urticaria Forecast
        10.1.5 Middle East & Africa Chronic Spontaneous Urticaria Forecast
    10.2 Americas Chronic Spontaneous Urticaria Forecast by Country (2026-2031)
        10.2.1 United States Market Chronic Spontaneous Urticaria Forecast
        10.2.2 Canada Market Chronic Spontaneous Urticaria Forecast
        10.2.3 Mexico Market Chronic Spontaneous Urticaria Forecast
        10.2.4 Brazil Market Chronic Spontaneous Urticaria Forecast
    10.3 APAC Chronic Spontaneous Urticaria Forecast by Region (2026-2031)
        10.3.1 China Chronic Spontaneous Urticaria Market Forecast
        10.3.2 Japan Market Chronic Spontaneous Urticaria Forecast
        10.3.3 Korea Market Chronic Spontaneous Urticaria Forecast
        10.3.4 Southeast Asia Market Chronic Spontaneous Urticaria Forecast
        10.3.5 India Market Chronic Spontaneous Urticaria Forecast
        10.3.6 Australia Market Chronic Spontaneous Urticaria Forecast
    10.4 Europe Chronic Spontaneous Urticaria Forecast by Country (2026-2031)
        10.4.1 Germany Market Chronic Spontaneous Urticaria Forecast
        10.4.2 France Market Chronic Spontaneous Urticaria Forecast
        10.4.3 UK Market Chronic Spontaneous Urticaria Forecast
        10.4.4 Italy Market Chronic Spontaneous Urticaria Forecast
        10.4.5 Russia Market Chronic Spontaneous Urticaria Forecast
    10.5 Middle East & Africa Chronic Spontaneous Urticaria Forecast by Region (2026-2031)
        10.5.1 Egypt Market Chronic Spontaneous Urticaria Forecast
        10.5.2 South Africa Market Chronic Spontaneous Urticaria Forecast
        10.5.3 Israel Market Chronic Spontaneous Urticaria Forecast
        10.5.4 Turkey Market Chronic Spontaneous Urticaria Forecast
    10.6 Global Chronic Spontaneous Urticaria Forecast by Type (2026-2031)
    10.7 Global Chronic Spontaneous Urticaria Forecast by Application (2026-2031)
        10.7.1 GCC Countries Market Chronic Spontaneous Urticaria Forecast

11 Key Players Analysis
11.1 Mylan N. V.
11.1.1 Mylan N. V. Company Information
11.1.2 Mylan N. V. Chronic Spontaneous Urticaria Product Offered
11.1.3 Mylan N. V. Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Mylan N. V. Main Business Overview
11.1.5 Mylan N. V. Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Chronic Spontaneous Urticaria Product Offered
11.2.3 Sanofi Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Chronic Spontaneous Urticaria Product Offered
11.3.3 GlaxoSmithKline Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 GlaxoSmithKline Main Business Overview
11.3.5 GlaxoSmithKline Latest Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Chronic Spontaneous Urticaria Product Offered
11.4.3 Bayer Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Bayer Main Business Overview
11.4.5 Bayer Latest Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Chronic Spontaneous Urticaria Product Offered
11.5.3 Merck Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Merck Main Business Overview
11.5.5 Merck Latest Developments
11.6 Aurobindo Pharma
11.6.1 Aurobindo Pharma Company Information
11.6.2 Aurobindo Pharma Chronic Spontaneous Urticaria Product Offered
11.6.3 Aurobindo Pharma Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Aurobindo Pharma Main Business Overview
11.6.5 Aurobindo Pharma Latest Developments
11.7 Hikma Pharmaceuticals
11.7.1 Hikma Pharmaceuticals Company Information
11.7.2 Hikma Pharmaceuticals Chronic Spontaneous Urticaria Product Offered
11.7.3 Hikma Pharmaceuticals Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Hikma Pharmaceuticals Main Business Overview
11.7.5 Hikma Pharmaceuticals Latest Developments
11.8 WOCKHARDT
11.8.1 WOCKHARDT Company Information
11.8.2 WOCKHARDT Chronic Spontaneous Urticaria Product Offered
11.8.3 WOCKHARDT Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 WOCKHARDT Main Business Overview
11.8.5 WOCKHARDT Latest Developments
11.9 AbbVie, Inc.
11.9.1 AbbVie, Inc. Company Information
11.9.2 AbbVie, Inc. Chronic Spontaneous Urticaria Product Offered
11.9.3 AbbVie, Inc. Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 AbbVie, Inc. Main Business Overview
11.9.5 AbbVie, Inc. Latest Developments
11.10 Cipla Inc.
11.10.1 Cipla Inc. Company Information
11.10.2 Cipla Inc. Chronic Spontaneous Urticaria Product Offered
11.10.3 Cipla Inc. Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Cipla Inc. Main Business Overview
11.10.5 Cipla Inc. Latest Developments
11.11 F. Hoffmann La Roche Ltd.
11.11.1 F. Hoffmann La Roche Ltd. Company Information
11.11.2 F. Hoffmann La Roche Ltd. Chronic Spontaneous Urticaria Product Offered
11.11.3 F. Hoffmann La Roche Ltd. Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 F. Hoffmann La Roche Ltd. Main Business Overview
11.11.5 F. Hoffmann La Roche Ltd. Latest Developments
11.12 Teva Pharmaceutical Industries, Ltd.
11.12.1 Teva Pharmaceutical Industries, Ltd. Company Information
11.12.2 Teva Pharmaceutical Industries, Ltd. Chronic Spontaneous Urticaria Product Offered
11.12.3 Teva Pharmaceutical Industries, Ltd. Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Teva Pharmaceutical Industries, Ltd. Main Business Overview
11.12.5 Teva Pharmaceutical Industries, Ltd. Latest Developments
11.13 Pfizer, Inc.
11.13.1 Pfizer, Inc. Company Information
11.13.2 Pfizer, Inc. Chronic Spontaneous Urticaria Product Offered
11.13.3 Pfizer, Inc. Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Pfizer, Inc. Main Business Overview
11.13.5 Pfizer, Inc. Latest Developments
11.14 Novartis AG
11.14.1 Novartis AG Company Information
11.14.2 Novartis AG Chronic Spontaneous Urticaria Product Offered
11.14.3 Novartis AG Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Novartis AG Main Business Overview
11.14.5 Novartis AG Latest Developments
11.15 Eli Lilly and Company
11.15.1 Eli Lilly and Company Company Information
11.15.2 Eli Lilly and Company Chronic Spontaneous Urticaria Product Offered
11.15.3 Eli Lilly and Company Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Eli Lilly and Company Main Business Overview
11.15.5 Eli Lilly and Company Latest Developments
11.16 Allergan
11.16.1 Allergan Company Information
11.16.2 Allergan Chronic Spontaneous Urticaria Product Offered
11.16.3 Allergan Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Allergan Main Business Overview
11.16.5 Allergan Latest Developments
11.17 Lupin
11.17.1 Lupin Company Information
11.17.2 Lupin Chronic Spontaneous Urticaria Product Offered
11.17.3 Lupin Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Lupin Main Business Overview
11.17.5 Lupin Latest Developments

12 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Chronic Spontaneous Urticaria Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
 Table 2. Chronic Spontaneous Urticaria Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Antihistamine
 Table 4. Major Players of Monoclonal Antibody
 Table 5. Major Players of Other
 Table 6. Chronic Spontaneous Urticaria Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
 Table 7. Global Chronic Spontaneous Urticaria Market Size by Type (2020-2025) & ($ millions)
 Table 8. Global Chronic Spontaneous Urticaria Market Size Market Share by Type (2020-2025)
 Table 9. Chronic Spontaneous Urticaria Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
 Table 10. Global Chronic Spontaneous Urticaria Market Size by Application (2020-2025) & ($ millions)
 Table 11. Global Chronic Spontaneous Urticaria Market Size Market Share by Application (2020-2025)
 Table 12. Global Chronic Spontaneous Urticaria Revenue by Player (2020-2025) & ($ millions)
 Table 13. Global Chronic Spontaneous Urticaria Revenue Market Share by Player (2020-2025)
 Table 14. Chronic Spontaneous Urticaria Key Players Head office and Products Offered
 Table 15. Chronic Spontaneous Urticaria Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 16. New Products and Potential Entrants
 Table 17. Mergers & Acquisitions, Expansion
 Table 18. Global Chronic Spontaneous Urticaria Market Size by Region (2020-2025) & ($ millions)
 Table 19. Global Chronic Spontaneous Urticaria Market Size Market Share by Region (2020-2025)
 Table 20. Global Chronic Spontaneous Urticaria Revenue by Country/Region (2020-2025) & ($ millions)
 Table 21. Global Chronic Spontaneous Urticaria Revenue Market Share by Country/Region (2020-2025)
 Table 22. Americas Chronic Spontaneous Urticaria Market Size by Country (2020-2025) & ($ millions)
 Table 23. Americas Chronic Spontaneous Urticaria Market Size Market Share by Country (2020-2025)
 Table 24. Americas Chronic Spontaneous Urticaria Market Size by Type (2020-2025) & ($ millions)
 Table 25. Americas Chronic Spontaneous Urticaria Market Size Market Share by Type (2020-2025)
 Table 26. Americas Chronic Spontaneous Urticaria Market Size by Application (2020-2025) & ($ millions)
 Table 27. Americas Chronic Spontaneous Urticaria Market Size Market Share by Application (2020-2025)
 Table 28. APAC Chronic Spontaneous Urticaria Market Size by Region (2020-2025) & ($ millions)
 Table 29. APAC Chronic Spontaneous Urticaria Market Size Market Share by Region (2020-2025)
 Table 30. APAC Chronic Spontaneous Urticaria Market Size by Type (2020-2025) & ($ millions)
 Table 31. APAC Chronic Spontaneous Urticaria Market Size by Application (2020-2025) & ($ millions)
 Table 32. Europe Chronic Spontaneous Urticaria Market Size by Country (2020-2025) & ($ millions)
 Table 33. Europe Chronic Spontaneous Urticaria Market Size Market Share by Country (2020-2025)
 Table 34. Europe Chronic Spontaneous Urticaria Market Size by Type (2020-2025) & ($ millions)
 Table 35. Europe Chronic Spontaneous Urticaria Market Size by Application (2020-2025) & ($ millions)
 Table 36. Middle East & Africa Chronic Spontaneous Urticaria Market Size by Region (2020-2025) & ($ millions)
 Table 37. Middle East & Africa Chronic Spontaneous Urticaria Market Size by Type (2020-2025) & ($ millions)
 Table 38. Middle East & Africa Chronic Spontaneous Urticaria Market Size by Application (2020-2025) & ($ millions)
 Table 39. Key Market Drivers & Growth Opportunities of Chronic Spontaneous Urticaria
 Table 40. Key Market Challenges & Risks of Chronic Spontaneous Urticaria
 Table 41. Key Industry Trends of Chronic Spontaneous Urticaria
 Table 42. Global Chronic Spontaneous Urticaria Market Size Forecast by Region (2026-2031) & ($ millions)
 Table 43. Global Chronic Spontaneous Urticaria Market Size Market Share Forecast by Region (2026-2031)
 Table 44. Global Chronic Spontaneous Urticaria Market Size Forecast by Type (2026-2031) & ($ millions)
 Table 45. Global Chronic Spontaneous Urticaria Market Size Forecast by Application (2026-2031) & ($ millions)
 Table 46. Mylan N. V. Details, Company Type, Chronic Spontaneous Urticaria Area Served and Its Competitors
 Table 47. Mylan N. V. Chronic Spontaneous Urticaria Product Offered
 Table 48. Mylan N. V. Chronic Spontaneous Urticaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 49. Mylan N. V. Main Business
 Table 50. Mylan N. V. Latest Developments
 Table 51. Sanofi Details, Company Type, Chronic Spontaneous Urticaria Area Served and Its Competitors
 Table 52. Sanofi Chronic Spontaneous Urticaria Product Offered
 Table 53. Sanofi Chronic Spontaneous Urticaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 54. Sanofi Main Business
 Table 55. Sanofi Latest Developments
 Table 56. GlaxoSmithKline Details, Company Type, Chronic Spontaneous Urticaria Area Served and Its Competitors
 Table 57. GlaxoSmithKline Chronic Spontaneous Urticaria Product Offered
 Table 58. GlaxoSmithKline Chronic Spontaneous Urticaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 59. GlaxoSmithKline Main Business
 Table 60. GlaxoSmithKline Latest Developments
 Table 61. Bayer Details, Company Type, Chronic Spontaneous Urticaria Area Served and Its Competitors
 Table 62. Bayer Chronic Spontaneous Urticaria Product Offered
 Table 63. Bayer Chronic Spontaneous Urticaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 64. Bayer Main Business
 Table 65. Bayer Latest Developments
 Table 66. Merck Details, Company Type, Chronic Spontaneous Urticaria Area Served and Its Competitors
 Table 67. Merck Chronic Spontaneous Urticaria Product Offered
 Table 68. Merck Chronic Spontaneous Urticaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 69. Merck Main Business
 Table 70. Merck Latest Developments
 Table 71. Aurobindo Pharma Details, Company Type, Chronic Spontaneous Urticaria Area Served and Its Competitors
 Table 72. Aurobindo Pharma Chronic Spontaneous Urticaria Product Offered
 Table 73. Aurobindo Pharma Chronic Spontaneous Urticaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 74. Aurobindo Pharma Main Business
 Table 75. Aurobindo Pharma Latest Developments
 Table 76. Hikma Pharmaceuticals Details, Company Type, Chronic Spontaneous Urticaria Area Served and Its Competitors
 Table 77. Hikma Pharmaceuticals Chronic Spontaneous Urticaria Product Offered
 Table 78. Hikma Pharmaceuticals Chronic Spontaneous Urticaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 79. Hikma Pharmaceuticals Main Business
 Table 80. Hikma Pharmaceuticals Latest Developments
 Table 81. WOCKHARDT Details, Company Type, Chronic Spontaneous Urticaria Area Served and Its Competitors
 Table 82. WOCKHARDT Chronic Spontaneous Urticaria Product Offered
 Table 83. WOCKHARDT Chronic Spontaneous Urticaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 84. WOCKHARDT Main Business
 Table 85. WOCKHARDT Latest Developments
 Table 86. AbbVie, Inc. Details, Company Type, Chronic Spontaneous Urticaria Area Served and Its Competitors
 Table 87. AbbVie, Inc. Chronic Spontaneous Urticaria Product Offered
 Table 88. AbbVie, Inc. Chronic Spontaneous Urticaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 89. AbbVie, Inc. Main Business
 Table 90. AbbVie, Inc. Latest Developments
 Table 91. Cipla Inc. Details, Company Type, Chronic Spontaneous Urticaria Area Served and Its Competitors
 Table 92. Cipla Inc. Chronic Spontaneous Urticaria Product Offered
 Table 93. Cipla Inc. Chronic Spontaneous Urticaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 94. Cipla Inc. Main Business
 Table 95. Cipla Inc. Latest Developments
 Table 96. F. Hoffmann La Roche Ltd. Details, Company Type, Chronic Spontaneous Urticaria Area Served and Its Competitors
 Table 97. F. Hoffmann La Roche Ltd. Chronic Spontaneous Urticaria Product Offered
 Table 98. F. Hoffmann La Roche Ltd. Chronic Spontaneous Urticaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 99. F. Hoffmann La Roche Ltd. Main Business
 Table 100. F. Hoffmann La Roche Ltd. Latest Developments
 Table 101. Teva Pharmaceutical Industries, Ltd. Details, Company Type, Chronic Spontaneous Urticaria Area Served and Its Competitors
 Table 102. Teva Pharmaceutical Industries, Ltd. Chronic Spontaneous Urticaria Product Offered
 Table 103. Teva Pharmaceutical Industries, Ltd. Chronic Spontaneous Urticaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 104. Teva Pharmaceutical Industries, Ltd. Main Business
 Table 105. Teva Pharmaceutical Industries, Ltd. Latest Developments
 Table 106. Pfizer, Inc. Details, Company Type, Chronic Spontaneous Urticaria Area Served and Its Competitors
 Table 107. Pfizer, Inc. Chronic Spontaneous Urticaria Product Offered
 Table 108. Pfizer, Inc. Chronic Spontaneous Urticaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 109. Pfizer, Inc. Main Business
 Table 110. Pfizer, Inc. Latest Developments
 Table 111. Novartis AG Details, Company Type, Chronic Spontaneous Urticaria Area Served and Its Competitors
 Table 112. Novartis AG Chronic Spontaneous Urticaria Product Offered
 Table 113. Novartis AG Chronic Spontaneous Urticaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 114. Novartis AG Main Business
 Table 115. Novartis AG Latest Developments
 Table 116. Eli Lilly and Company Details, Company Type, Chronic Spontaneous Urticaria Area Served and Its Competitors
 Table 117. Eli Lilly and Company Chronic Spontaneous Urticaria Product Offered
 Table 118. Eli Lilly and Company Chronic Spontaneous Urticaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 119. Eli Lilly and Company Main Business
 Table 120. Eli Lilly and Company Latest Developments
 Table 121. Allergan Details, Company Type, Chronic Spontaneous Urticaria Area Served and Its Competitors
 Table 122. Allergan Chronic Spontaneous Urticaria Product Offered
 Table 123. Allergan Chronic Spontaneous Urticaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 124. Allergan Main Business
 Table 125. Allergan Latest Developments
 Table 126. Lupin Details, Company Type, Chronic Spontaneous Urticaria Area Served and Its Competitors
 Table 127. Lupin Chronic Spontaneous Urticaria Product Offered
 Table 128. Lupin Chronic Spontaneous Urticaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 129. Lupin Main Business
 Table 130. Lupin Latest Developments


List of Figures
 Figure 1. Chronic Spontaneous Urticaria Report Years Considered
 Figure 2. Research Objectives
 Figure 3. Research Methodology
 Figure 4. Research Process and Data Source
 Figure 5. Global Chronic Spontaneous Urticaria Market Size Growth Rate (2020-2031) ($ millions)
 Figure 6. Chronic Spontaneous Urticaria Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 7. Chronic Spontaneous Urticaria Sales Market Share by Country/Region (2024)
 Figure 8. Chronic Spontaneous Urticaria Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 9. Global Chronic Spontaneous Urticaria Market Size Market Share by Type in 2024
 Figure 10. Chronic Spontaneous Urticaria in Children
 Figure 11. Global Chronic Spontaneous Urticaria Market: Children (2020-2025) & ($ millions)
 Figure 12. Chronic Spontaneous Urticaria in Adult
 Figure 13. Global Chronic Spontaneous Urticaria Market: Adult (2020-2025) & ($ millions)
 Figure 14. Global Chronic Spontaneous Urticaria Market Size Market Share by Application in 2024
 Figure 15. Global Chronic Spontaneous Urticaria Revenue Market Share by Player in 2024
 Figure 16. Global Chronic Spontaneous Urticaria Market Size Market Share by Region (2020-2025)
 Figure 17. Americas Chronic Spontaneous Urticaria Market Size 2020-2025 ($ millions)
 Figure 18. APAC Chronic Spontaneous Urticaria Market Size 2020-2025 ($ millions)
 Figure 19. Europe Chronic Spontaneous Urticaria Market Size 2020-2025 ($ millions)
 Figure 20. Middle East & Africa Chronic Spontaneous Urticaria Market Size 2020-2025 ($ millions)
 Figure 21. Americas Chronic Spontaneous Urticaria Value Market Share by Country in 2024
 Figure 22. United States Chronic Spontaneous Urticaria Market Size Growth 2020-2025 ($ millions)
 Figure 23. Canada Chronic Spontaneous Urticaria Market Size Growth 2020-2025 ($ millions)
 Figure 24. Mexico Chronic Spontaneous Urticaria Market Size Growth 2020-2025 ($ millions)
 Figure 25. Brazil Chronic Spontaneous Urticaria Market Size Growth 2020-2025 ($ millions)
 Figure 26. APAC Chronic Spontaneous Urticaria Market Size Market Share by Region in 2024
 Figure 27. APAC Chronic Spontaneous Urticaria Market Size Market Share by Type (2020-2025)
 Figure 28. APAC Chronic Spontaneous Urticaria Market Size Market Share by Application (2020-2025)
 Figure 29. China Chronic Spontaneous Urticaria Market Size Growth 2020-2025 ($ millions)
 Figure 30. Japan Chronic Spontaneous Urticaria Market Size Growth 2020-2025 ($ millions)
 Figure 31. South Korea Chronic Spontaneous Urticaria Market Size Growth 2020-2025 ($ millions)
 Figure 32. Southeast Asia Chronic Spontaneous Urticaria Market Size Growth 2020-2025 ($ millions)
 Figure 33. India Chronic Spontaneous Urticaria Market Size Growth 2020-2025 ($ millions)
 Figure 34. Australia Chronic Spontaneous Urticaria Market Size Growth 2020-2025 ($ millions)
 Figure 35. Europe Chronic Spontaneous Urticaria Market Size Market Share by Country in 2024
 Figure 36. Europe Chronic Spontaneous Urticaria Market Size Market Share by Type (2020-2025)
 Figure 37. Europe Chronic Spontaneous Urticaria Market Size Market Share by Application (2020-2025)
 Figure 38. Germany Chronic Spontaneous Urticaria Market Size Growth 2020-2025 ($ millions)
 Figure 39. France Chronic Spontaneous Urticaria Market Size Growth 2020-2025 ($ millions)
 Figure 40. UK Chronic Spontaneous Urticaria Market Size Growth 2020-2025 ($ millions)
 Figure 41. Italy Chronic Spontaneous Urticaria Market Size Growth 2020-2025 ($ millions)
 Figure 42. Russia Chronic Spontaneous Urticaria Market Size Growth 2020-2025 ($ millions)
 Figure 43. Middle East & Africa Chronic Spontaneous Urticaria Market Size Market Share by Region (2020-2025)
 Figure 44. Middle East & Africa Chronic Spontaneous Urticaria Market Size Market Share by Type (2020-2025)
 Figure 45. Middle East & Africa Chronic Spontaneous Urticaria Market Size Market Share by Application (2020-2025)
 Figure 46. Egypt Chronic Spontaneous Urticaria Market Size Growth 2020-2025 ($ millions)
 Figure 47. South Africa Chronic Spontaneous Urticaria Market Size Growth 2020-2025 ($ millions)
 Figure 48. Israel Chronic Spontaneous Urticaria Market Size Growth 2020-2025 ($ millions)
 Figure 49. Turkey Chronic Spontaneous Urticaria Market Size Growth 2020-2025 ($ millions)
 Figure 50. GCC Countries Chronic Spontaneous Urticaria Market Size Growth 2020-2025 ($ millions)
 Figure 51. Americas Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)
 Figure 52. APAC Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)
 Figure 53. Europe Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)
 Figure 54. Middle East & Africa Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)
 Figure 55. United States Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)
 Figure 56. Canada Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)
 Figure 57. Mexico Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)
 Figure 58. Brazil Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)
 Figure 59. China Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)
 Figure 60. Japan Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)
 Figure 61. Korea Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)
 Figure 62. Southeast Asia Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)
 Figure 63. India Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)
 Figure 64. Australia Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)
 Figure 65. Germany Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)
 Figure 66. France Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)
 Figure 67. UK Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)
 Figure 68. Italy Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)
 Figure 69. Russia Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)
 Figure 70. Egypt Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)
 Figure 71. South Africa Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)
 Figure 72. Israel Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)
 Figure 73. Turkey Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)
 Figure 74. Global Chronic Spontaneous Urticaria Market Size Market Share Forecast by Type (2026-2031)
 Figure 75. Global Chronic Spontaneous Urticaria Market Size Market Share Forecast by Application (2026-2031)
 Figure 76. GCC Countries Chronic Spontaneous Urticaria Market Size 2026-2031 ($ millions)

Companies Mentioned

Mylan N. V.

Sanofi

GlaxoSmithKline

Bayer

Merck

Aurobindo Pharma

Hikma Pharmaceuticals

WOCKHARDT

AbbVie, Inc.

Cipla Inc.

F. Hoffmann La Roche Ltd.

Teva Pharmaceutical Industries, Ltd.

Pfizer, Inc.

Novartis AG

Eli Lilly and Company

Allergan

Lupin

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff